A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PPG / postprandial glucose

[Related PubMed/MEDLINE]
Total Number of Papers: 219
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PPG  (>> Co-occurring Abbreviation)
Long Form:   postprandial glucose
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A novel non-PPARgamma insulin sensitizer: MLR-1023 clinicalproof-of-concept in type 2 diabetes mellitus. FPG, MMTT
2020 A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (ONSET 9). BG, ETD, IAsp
2020 A survey of physician experience and treatment satisfaction using fast-acting insulin aspart in people with type 1 or type 2 diabetes. ---
2020 Achieving postprandial glucose control with lixisenatide improves glycemic control in patients with type 2 diabetes on basal insulin: a post-hoc analysis of pooled data. FPG, T2D
2020 Acute glycemic and insulinemic effects of low-energy sweeteners: a systematic review and meta-analysis of randomized controlled trials. LES, PPI
2020 Comparison of Glycemic Excursion Using Flash Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus Before and After Treatment with Voglibose. FPG, MAGE, MET
2020 Effect of 1,5-anhydroglucitol levels on culprit plaque rupture in diabetic patients with acute coronary syndrome. 1,5-AG, 8-iso-PGF2alpha, ACS, CAD, FBG, HbA1c
2020 Epidemiological Features of Glycemic Levels and Relative Determinants at Different Altitudes Among Tibetans in China: A Cross-Sectional Population-Based Study. FPG, INS, TC
2020 Impact of isocaloric exchanges of carbohydrate for fat on postprandial glucose, insulin, triglycerides, and free fatty acid responses-a systematic review and meta-analysis. ---
10  2020 Postprandial glucose response moderation by cardiorespiratory fitness following short exercise bouts. CRF, OGTT
11  2020 Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2D. ETD, URLi
12  2020 Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes. CI, EOT, GV, RAIAs, RHI, T1D, T2D
13  2020 Reducing postprandial glucose in dietary intervention studies and the magnitude of the effect on diabetes-related risk factors: a systematic review and meta-analysis. FPG, MD
14  2020 Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption. AUC, RaO, SGLT
15  2020 The effect of 8 plant extracts and combinations on post-prandial blood glucose and insulin responses in healthy adults: a randomized controlled trial. ---
16  2020 The effect of a low glycaemic index diet on reducing day-long glycaemia in healthy young adults: A randomized crossover trial. HGI, iAUC, LGI, MPGR
17  2020 The role of text messaging intervention in Inner Mongolia among patients with type 2 diabetes mellitus: a randomized controlled trial. CG, FPG, IG, SMS
18  2020 Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26-week PRONTO-T1D study. CI, ETD, URLi
19  2020 Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog in Japanese Patients With Type 2 Diabetes: PRONTO-T2D Subpopulation Analysis. CI, HbA1c, LSM, T2DM, URLi
20  2020 Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog in Japanese Patients with Type1 Diabetes: PRONTO-T1D Subpopulation Analysis. CI, HbA1c, LSM, URLi
21  2020 Ultra-Rapid Lispro Improves Postprandial Glucose Control and Time in Range in Type 1 Diabetes Compared to Lispro: PRONTO-T1D Continuous Glucose Monitoring Substudy. CGM, LSM, URLi
22  2019 A randomized, multicentre trial evaluating the efficacy and safety of fast-acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5). CI, CSII, ETD, IAsp, T1D
23  2019 Ascophyllum Nodosum, Fucus Vesiculosus and chromium picolinate nutraceutical composition can help to treat type 2 diabetic patients. FPG
24  2019 Baseline nocturnal glucose change: A predictor of the treatment effect of bolus intensification in insulin-treated type 2 diabetes. T2D
25  2019 Behavioral Strategies to Lower Postprandial Glucose in Those with Type 2 Diabetes May Also Lower Risk of Coronary Heart Disease. CHD, T2D, UKPDS
26  2019 Better glycaemic control with BioChaperone glargine lispro co-formulation than with insulin lispro Mix25 or separate glargine and lispro administrations after a test meal in people with type 2 diabetes. PK, T2DM
27  2019 Dose-dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12 weeks: The inTandem4 trial. DKA, LSM, T1D, UGE
28  2019 Effect of once-weekly dulaglutide versus insulin glargine in people with type 2 diabetes and different baseline glycaemic patterns: A post hoc analysis of the AWARD-2 clinical trial. FG
29  2019 Efficacy of DPP4i as the Fourth Drug in the Management of Type2 Diabetes Mellitus in Asian Indians Poorly Controlled by Use of at least 3 Oral Antidiabetic Drugs. DPP-4i
30  2019 Fast-Acting Insulin Aspart and the Need for New Mealtime Insulin Analogues in Adults With Type 1 and Type 2 Diabetes: A Canadian Perspective. IAsp, RAIAs
31  2019 Gestational Diabetes Mellitus: The Impact of Carbohydrate Quality in Diet. GDM, LGI
32  2019 Glycemic and Insulinemic Responses of Vegetables and Beans Powders Supplemented Chapattis in Healthy Humans: A Randomized, Crossover Trial. APFC, AUC, BPSC, PPI, VPSC
33  2019 Impact of lixisenatide dose range on clinical outcomes with fixed-ratio combination iGlarLixi in patients with type 2 diabetes. FPG
34  2019 Importance of Postprandial Glucose in Relation to A1C and Cardiovascular Disease. CVD
35  2019 Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program. CGM, SGLT, TIR
36  2019 Managing free-living hyperglycemia with exercise or interrupted sitting in type 2 diabetes. CON, PA, WALK
37  2019 Optimizing Postprandial Glucose Management in Adults With Insulin-Requiring Diabetes: Report and Recommendations. ---
38  2019 Post hoc efficacy and safety analysis of insulin glargine/lixisenatide fixed- ratio combination in North American patients compared with the rest of world. FPG, GI, IGlar, NA, ROW, T2D
39  2019 The Differential and Combined Action of Insulin Glargine and Lixisenatide on the Fasting and Postprandial Components of Glucose Control. AUC, FMPG, FPG, HBGI, IGlar, PHBGI, PMPG
40  2019 The Rate of Glucose Appearance Is Related to Postprandial Glucose and Insulin Responses in Adults: A Systematic Review and Meta-analysis of Stable Isotope Studies. EGP, RaE, RdT
41  2019 Use of fast-acting insulin aspart in insulin pump therapy in clinical practice. CSII, ETD, IAsp, T1D
42  2018 A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients. ARBs, BMI, BP, eGFR, FPG, FPI, HCTZ, TC, TG
43  2018 An Evaluation of the Clinical Therapeutic Effect of Lixisenatide in Type 2 Diabetes Patients: A Systematic Literature Review. ---
44  2018 Choice of Treatment Regimen as Add-On to Insulin in Japanese Patients with Type 2 Diabetes Mellitus: Physicians' Perspective in a Real-World Setting, Insight from a Web Survey. BMI, DPP-4, OADGs, T2DM
45  2018 Combined SGLT1 and SGLT2 Inhibitors and Their Role in Diabetes Care. DKA, SGLT1, SGLT2, T1DM, T2DM
46  2018 Consistency of Continuous Ambulatory Interstitial Glucose Monitoring Sensors. CGM, FG
47  2018 Development of a Collaborative Algorithm for the Management of Type 2 Diabetes during Ramadan: An Anchor on Empowerment. FPG
48  2018 Disparities in the Efficacy of Metformin in Combination with Dipeptidyl Peptidase-4 Inhibitor as Initial Treatment Stratified by Dosage and Ethnicity: A Meta-Analysis. DPP-4, FPG, HbA1c
49  2018 Drinking water with consumption of a jelly filled doughnut has a time dependent effect on the postprandial blood glucose level in healthy young individuals. ---
50  2018 EADSG Guidelines: Insulin Therapy in Diabetes. FPG, GLP-1RA, HbA1c, IM, OADs, SMBG, T1DM, T2DM
51  2018 Efficacy and Safety of Teneligliptin in Indian Patients with Inadequately Controlled Type 2 Diabetes Mellitus: A Randomized, Double-blind Study. CIs, FPG, ITT, LS, PP, T2DM
52  2018 Factors Influencing the Prescribing Preferences of Physicians for Drug-Naive Patients with Type 2 Diabetes Mellitus in the Real-World Setting in Japan: Insight from a Web Survey. DPP-4is, OAD, T2DM
53  2018 Greater early postprandial suppression of endogenous glucose production and higher initial glucose disappearance is achieved with fast-acting insulin aspart compared with insulin aspart. CI, EGP, IAsp
54  2018 Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety. FBG, IDeg
55  2018 Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study. CGM, MDI, PPGE, TI, TIR
56  2018 Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies. GLP-1, RAI, RAs, T2D
57  2018 Postprandial glucose and healthcare resource use: a cross-sectional survey of adults with diabetes treated with basal-bolus insulin. HCP, IRR
58  2018 Prevalence of thyroid disorders in North Indian Type 2 diabetic subjects: A cross sectional study. FBS, HDL, LDL, T2DM, VLDL
59  2018 Real-world use of self-monitoring of blood glucose in people with type 2 diabetes: an urgent need for improvement. FBG, SMBG
60  2018 Relative Contribution of Fasting and Postprandial Blood Glucose in Overall Glycemic Control: Post Hoc Analysis of a Phase IV Randomized Trial. BG, FBG, LM25, LM50
61  2018 Relative contributions of preprandial and postprandial glucose exposures, glycemic variability, and non-glycemic factors to HbA 1c in individuals with and without diabetes. T2D
62  2017 A meta-analysis of efficacy of Morus alba Linn. to improve blood glucose and lipid profile. ---
63  2017 A randomized, placebo- and sitagliptin-controlled trial of the safety and efficacy of omarigliptin, a once-weekly dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes. FPG, LS, T2D
64  2017 A utility valuation study assessing the impact of postprandial glucose control on quality of life of individuals with type 1 or type 2 diabetes. HRQoL, TTO
65  2017 Association of periodontal disease with glycemic control in patients with type 2 diabetes in Indian population. BMI, CP, FPG, PH, PISA, PPD, SES
66  2017 Effect of exercise timing on elevated postprandial glucose levels. ---
67  2017 Efficacy of different fibres and flour mixes in South-Asian flatbreads for reducing post-prandial glucose responses in healthy adults. CPF, GG, KM
68  2017 Efficacy of fibre additions to flatbread flour mixes for reducing post-meal glucose and insulin responses in healthy Indian subjects. CPF, GG, PPI, T2DM
69  2017 Evidence based study of antidiabetic potential of C. maxima seeds-Invivo. BGL, CMSE, FBG, GTT
70  2017 Exenatide once weekly improved 24-hour glucose control and reduced glycaemic variability in metformin-treated participants with type 2 diabetes: a randomized, placebo-controlled trial. CGM, FPG, MAGE, SD
71  2017 Glycemic control and safety in Chinese patients with type 2 diabetes mellitus who switched from premixed insulin to insulin glargine plus oral antidiabetics: a large, prospective, observational study. FPG, OADs, T2DM
72  2017 Glycemic index, glycemic load, and glycemic response to pomelo in patients with type 2 diabetes. GI, GL, T2D
73  2017 Impact of improving postprandial glycemic control with intensifying insulin therapy in type 2 diabetes. CSII
74  2017 Liraglutide and Metformin alone or combined therapy for type 2 diabetes patients complicated with coronary artery disease. BMI, BP, CRP, EF, FBG, LDL-C, LVEDD, TC, TG, Tianjin, China
75  2017 Lixisenatide reduces glycaemic variability in insulin-treated patients with type 2 diabetes. AUC-F, GV, LBGI, Lixi, MAG, MAGE, SD
76  2017 Lixisenatide, a Once-Daily Prandial Glucagon-Like Peptide-1 Receptor Agonist for the Treatment of Adults with Type 2 Diabetes. ADA, FPG, GLP-1RA, HbA1c, T2D
77  2017 Rationale for treatment options for mealtime glucose control in patients with type 2 diabetes. GLP-1RAs
78  2017 Reduction of postprandial glucose by lixisenatide vs sitagliptin treatment in Japanese patients with type 2 diabetes on background insulin glargine: A randomized phase IV study (NEXTAGE Study). LS
79  2016 A Clinical Trial about a Food Supplement Containing alpha-Lipoic Acid on Oxidative Stress Markers in Type 2 Diabetic Patients. FPG, FPI, GSH-Px, hs-CRP, MDA, SOD
80  2016 BeAM value: an indicator of the need to initiate and intensify prandial therapy in patients with type 2 diabetes mellitus receiving basal insulin. OADs, T2DM
81  2016 Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study. BIAsp 30, FPG, QALY, T2DM
82  2016 Efficacy and safety of biphasic insulin aspart and biphasic insulin lispro mix in patients with type 2 diabetes: A review of the literature. BIAsp 30, OADs, T2D
83  2016 Efficacy and tolerability of exenatide twice daily and exenatide once weekly in Asian versus White patients with type 2 diabetes mellitus: A pooled analysis. FG, T2DM
84  2016 Efficacy of acarbose and metformin in newly diagnosed type 2 diabetes patients stratified by HbA1c levels. AUC, FPG, GLP-1, T2DM, TG
85  2016 Glycated apolipoprotein B-A surrogate marker of subclinical atherosclerosis. CAD, CIMT, FBG, HOMA-IR, HPLC, LDL, sdLDL
86  2016 Glycemic Index, Glycemic Load, and Lung Cancer Risk in Non-Hispanic Whites. CI, GI, GL, SCC
87  2016 Impact of postprandial glucose control on diabetes-related complications: How is the evidence evolving? ---
88  2016 Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator. TI, UVA
89  2016 Increased Glycated Hemoglobin Level is Associated With SYNTAX Score II in Patients With Type 2 Diabetes Mellitus. CAD, FBG, SS, SSII
90  2016 Lixisenatide Improves Glycemic Control in Asian Type 2 Diabetic Patients Inadequately Controlled With Oral Antidiabetic Drugs: An Individual Patient Data Meta-Analysis. OADs, T2DM
91  2016 Lixisenatide in type 2 diabetes: latest evidence and clinical usefulness. GLP-1, RAs, T2D
92  2016 The role of a fixed Berberis aristata/Silybum marianum combination in the treatment of type 1 diabetes mellitus. BMI, FPG
93  2016 Use of a basal-plus insulin regimen in persons with type 2 diabetes stratified by age and body mass index: A pooled analysis of four clinical trials. ---
94  2015 A systematic review of the influence of rice characteristics and processing methods on postprandial glycaemic and insulinaemic responses. GL
95  2015 Clinical Characteristics of Patients Responding to Once-Daily Basal Insulin Therapy in Korean Subjects with Type 2 Diabetes. BI, T2D
96  2015 Comparative evaluation of efficacy and safety of combination of metformin-vidagliptin versus metfromin-glimepiride in most frequently used doses in patients of type 2 diabetes mellitus with inadequately controlled metformin monotherapy-A randomised open label study. FBG, MF-GP, MF-VG, T2DM
97  2015 Contributions of Basal Glucose and Postprandial Glucose Concentrations to Hemoglobin A1c in the Newly Diagnosed Patients with Type 2 Diabetes--the Preliminary Study. BG, HbA1c, NGT, T2DM
98  2015 Differential effects of prandial and non-prandial GLP-1 receptor agonists in type 2 diabetes therapy. GLP-1RAs, T2DM
99  2015 Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study. CGM, CGM, CGM, MAGE, T2DM
100  2015 Garlic intake lowers fasting blood glucose: meta-analysis of randomized controlled trials. FBG